NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
1.930
-0.230 (-10.65%)
Mar 9, 2026, 4:00 PM EDT - Market closed
NuCana Market Cap
NuCana has a market cap or net worth of $8.62 million as of March 9, 2026. Its market cap has increased by 105.12% in one year.
Market Cap
8.62M
Enterprise Value
-24.77M
1-Year Change
105.12%
Ranking
Category
Stock Price
$1.93
Market Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $513.70M to $8.62M, a decrease of -98.32%. That is a compound annual growth rate of -38.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 9.00M | -40.00% |
| Dec 31, 2025 | 15.00M | 219.15% |
| Dec 31, 2024 | 4.70M | -69.87% |
| Dec 29, 2023 | 15.60M | -54.65% |
| Dec 30, 2022 | 34.40M | -72.30% |
| Dec 31, 2021 | 124.20M | -21.19% |
| Dec 31, 2020 | 157.60M | -19.84% |
| Dec 31, 2019 | 196.60M | -57.38% |
| Dec 31, 2018 | 461.30M | 43.44% |
| Dec 29, 2017 | 321.60M | -37.40% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moleculin Biotech | 10.26M |
| BioVie | 10.26M |
| Cardio Diagnostics Holdings | 9.68M |
| SeaStar Medical Holding | 9.08M |
| TransCode Therapeutics | 8.80M |
| Iterum Therapeutics | 8.74M |
| CollPlant Biotechnologies | 8.73M |
| Bolt Biotherapeutics | 8.25M |